Citalopram versus maprotiline: A controlled, clinical multicentre trial in depressed patients
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
In a double‐blind trial, comprising 96 depressed patients, citalopram was compared with maprotiline. The trial period was 6 weeks with ratings (MADRS, CGI) and side effects recordings taking place at Weeks 0, 1, 2, 4, and 6. Both drugs were administered as a single evening dose, 40 or 60 mg for citalopram, and 75 or 150 mg for maprotiline. MADRS total scores and CGI scores showed a highly significant reduction in both groups with no significant difference between them, whether the groups were considered as a whole or whether they were subdivided into endogenously/non‐endogenously depressed or melancholic/non‐melancholic patients. Side effects were not significantly different, but the maprotiline group showed more anticholinergic side effects, whereas the citalopram group showed more nausea, increased sweating and headache. Two patients on maprotiline were withdrawn because of side effects (hypotension and somnolence in the one case; tremor and insomnia in the other). One patient in each group was withdrawn because of increased transaminases, the citalopram‐treated patient having increased values, however, already at baseline. Apart from this, no cardiovascular side effects and no pathological laboratory values related to treatment were observed. The authors conclude that citalopram is a safe antidepressant drug and as effective as maprotiline.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ECDEU Assessment Manual: (591322011-001)
Guy, W. (1976) · PsycEXTRA Dataset · doi:10.1037/e591322011-001 · Cited by 1,896
Cited by
Anderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940
Toward a Neurodevelopmental Model of Obsessive–Compulsive Disorder
Rosenberg, D. R., & Keshavan, M. S. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00443-5 · Cited by 355
Citalopram versus other anti-depressive agents for depression
Cipriani, A., Purgato, M., Furukawa, T. A., Trespidi, C., Imperadore, G., Signoretti, A., Churchill, R., Watanabe, N., & Barbui, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006534.pub2 · Cited by 311
Nyth, A. L., Gottfries, C. G., Lyby, K., Smedegaard‐Andersen, L., Gylding‐Sabroe, J., Kristensen, M., Refsum, H. ‐., Öfsti, E., Eriksson, S., & Syversen, S. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb03242.x · Cited by 258
Dose-response relationship of recent antidepressants in the short-term treatment of depression
Berney, P. (2005) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2005.7.3/pberney · Cited by 39
Metadata
- Authors
- Bouchard, J. M., Delaunay, J., Delisle, J. ‐., Grasset, N., Mermberg, P. F., Molczadzki, M., Pagot, R., Richou, H., Robert, G., Ropert, R., Schuller, E., Verdeau‐Paillés, J., Zarifian, E., & Petersen, H. E. H.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 1987-11
- Volume
- 76
- Issue
- 5
- Pages
- 583-592
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W2110161339
- Cited by
- 45
- References
- 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Citalopram versus maprotiline: A controlled, clinical multicentre trial in depressed patients. https://app.cochat.ai/papers/10.1111/j.1600-0447.1987.tb02923.x
- The paper
- Bouchard, J. M., Delaunay, J., Delisle, J. ‐., Grasset, N., Mermberg, P. F., Molczadzki, M., Pagot, R., Richou, H., Robert, G., Ropert, R., Schuller, E., Verdeau‐Paillés, J., Zarifian, E., & Petersen, H. E. H. (1987). Citalopram versus maprotiline: A controlled, clinical multicentre trial in depressed patients. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.1987.tb02923.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.